A Case of Percutaneous Intracavitary Amphotericin B Injection for the Treatment of Hemoptysis due to Pulmonary Aspergilloma.
10.4046/trd.1994.41.1.42
- Author:
Woa Ja LIM
;
Kook Kyu KIM
;
Myung Jun KIM
;
Jong Gil WOO
;
Hong Suk KIM
;
Byung Ho KIM
- Publication Type:Case Report
- Keywords:
Pulmonary Aspergilloma;
Percutaneous Intracavitary Amphotericin B Injection
- MeSH:
Amphotericin B*;
Aspergillus;
Fasting;
Hemoptysis*;
Humans;
Lung Diseases;
Male
- From:Tuberculosis and Respiratory Diseases
1994;41(1):42-46
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pulmonary Aspergillomas usually arise from proliferation of Aspergillus in preexisting parenchymal cavities.202 college students (99 men, 103 women) aged 18% 26 years. Fasting blood samples were. The most common symptom in this disorder is hemoptysis, which may be minimal in amount or it may be massive & life threatening. The optimum therapy for pulmonary aspergilloma is controversial. The major options available include surgical resection of the lesion, a number of medical therapies, or simple observation of the patient for a time. Surgery is the most effective treatment but it is limited to some patient because most patients haute underlying pulmonary disease. Thus the various form of medical therapy was available with successful result. The authors present a case of percutaneous intracavitary amphoterician B injection for the treatment of pulmonary aspergilloma & its successful effect for the repetitive hemoptysis.
